Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage
NCT00827892Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Mar 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in intracerebral hemorrhage (ICH), sponsored by UTHealth Houston. Started Mar 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00827892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827892.